56% of reviewers reported a positive experience, while 23% reported a negative experience
Even though pain reduction is a huge plus, there are some Gabapentin for Pain User Reviews (Page 3) Brand names: Neurontin, Gralise, Gabarone, Fanatrex
Anxiety / Social Phobia
51% of reviewers reported a positive experience, while 34% reported a negative experience
47% of reviewers reported a positive experience, while 25% reported a negative experience
0 Effectiveness Ease of Use Satisfaction I have been on this medication on and off for around eight years
Gabapentin has an average rating of 6
Authors' conclusions: Gabapentin at doses of 1800 mg to 3600 mg daily (1200 mg to 3600 mg gabapentin encarbil) can provide good levels of pain relief to some people with
4 Overall Rating Share Your Experience Effectiveness Ease of Use Satisfaction Most voted positive review 117
But it’s also commonly used off-label to treat
Gabapentin (Neurontin, Gralise, Horizant) is a medicine used to help manage certain epileptic seizures
Gabapentin for Anxiety User Reviews
See what others have said about Gabapentin (Neurontin), including the effectiveness, ease of use and side effects
1
Effectiveness
But it’s also commonly used off-label to treat other types of nerve pain, including back pain
Below are Neurontin (Gabapentin) reviews, ratings, comments submitted by patients and caregivers
It is moderately effective: about 30–40% of
While the pain relief begins to be noticable at 300mg (and maintenance doses can range from 100mg to 900mg or so Neurontin (gabapentin) is an anti-eleptic medication used to treat seizures that occur with epilepsy, as well as nerve pain associated with shingles
seizures
View Free Coupon
However, nerve pain can be a long-term issue, lasting for three or more months
First-line drugs for neuropathic pain include antidepressants (tricyclic antidepressants and serotonin–noradrenaline reuptake inhibitors) and anticonvulsants acting at calcium channels (pregabalin and gabapentin)
Background: This review replaces part of an earlier review that evaluated gabapentin for both neuropathic pain and fibromyalgia, now split into separate reviews for the two conditions